| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | Chief Accounting Officer | Common Stock | 52,050 | $231,622 | $4.45 | 09 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | 09 Mar 2026 | 1 | $0 | 4 | Chief Accounting Officer | 11 Mar 2026, 17:45 |
| ATRA | Atara Biotherapeutics, Inc. | 02 Mar 2026 | 4 | -$10,691 | 4 | Chief Accounting Officer | 04 Mar 2026, 16:28 |
| ATRA | Atara Biotherapeutics, Inc. | 17 Nov 2025 | 3 | -$23,788 | 4 | Chief Accounting Officer | 19 Nov 2025, 16:55 |
| ATRA | Atara Biotherapeutics, Inc. | 18 Aug 2025 | 3 | -$21,009 | 4 | Chief Accounting Officer | 20 Aug 2025, 16:08 |
| ATRA | Atara Biotherapeutics, Inc. | 16 May 2025 | 1 | -$15,000 | 4 | Chief Accounting Officer | 20 May 2025, 16:59 |
| ATRA | Atara Biotherapeutics, Inc. | 31 Mar 2025 | 0 | $0 | 3 | Chief Accounting Officer | 10 Apr 2025, 19:14 |